Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
The Urologic Clinics of North America|May 3, 2016
Management of Hypogonadism in Cardiovascular Patients: What Are the Implications of Testosterone Therapy on Cardiovascular Morbidity?Monique S Tanna, Arthur Schwartzbard, Jeffery S Berger, et al.Journal of the American Society of Hypertension : JASH|April 24, 2012
Home and clinic blood pressure responses in elderly individuals with systolic hypertensionWilliam C Cushman, Daniel A Duprez, Howard S Weintraub, et al.Blood Pressure Monitoring|July 13, 2011
Effect of valsartan, hydrochlorothiazide, and their combination on 24-h ambulatory blood pressure response in elderly patients with systolic hypertension: a ValVET substudyDaniel A Duprez, Howard S Weintraub, William C Cushman, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|October 7, 2011
Treating systolic hypertension in the very elderly with valsartan-hydrochlorothiazide vs. either monotherapy: ValVET primary resultsJoseph L Izzo, Howard S Weintraub, Daniel A Duprez, et al.Journal of the American College of Cardiology|October 6, 2018
The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art ReviewJonathan D Newman, Anish K Vani, Jose O Aleman, et al.Cardiovascular Drugs and Therapy|February 8, 2012
Antihypertensive response to thiazide diuretic or angiotensin receptor blocker in elderly hypertensives is not influenced by pretreatment plasma renin activityHoward S Weintraub, Daniel A Duprez, William C Cushman, et al.Journal of the American College of Cardiology|August 20, 2016
Cardiovascular Effects of the New Weight Loss AgentsMatthew H Vorsanger, Pritha Subramanyam, Howard S Weintraub, et al.Diabetes Care|April 8, 2014
Diabetes and vascular disease in different arterial territoriesBinita Shah, Caron B Rockman, Yu Guo, et al.American Heart Journal|February 23, 2017
Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular diseaseJonathan D Newman, Caron B Rockman, Mikhail Kosiborod, et al.The American Journal of Cardiology|July 25, 2008
Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelinesMichael H Davidson, Marshall A Corson, Mark J Alberts, et al.Pageof 3